CS68791A3 - Novel 1-carboxalkylquinoline-2,3(1h,4h)dione compounds, process for their preparation and use - Google Patents

Novel 1-carboxalkylquinoline-2,3(1h,4h)dione compounds, process for their preparation and use Download PDF

Info

Publication number
CS68791A3
CS68791A3 CS91687A CS68791A CS68791A3 CS 68791 A3 CS68791 A3 CS 68791A3 CS 91687 A CS91687 A CS 91687A CS 68791 A CS68791 A CS 68791A CS 68791 A3 CS68791 A3 CS 68791A3
Authority
CS
Czechoslovakia
Prior art keywords
formula
compound
hydrogen
hydrogen atom
group
Prior art date
Application number
CS91687A
Other languages
Czech (cs)
English (en)
Inventor
Anker Steen Jorgensen
Carsten Enggaard Stidsen
Peter Faarup
Frederik Christian Gronvald
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of CS68791A3 publication Critical patent/CS68791A3/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/50Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
    • C07D241/52Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40Benzopyrazines
    • C07D241/44Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CS91687A 1990-03-16 1991-03-15 Novel 1-carboxalkylquinoline-2,3(1h,4h)dione compounds, process for their preparation and use CS68791A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK069790A DK69790D0 (da) 1990-03-16 1990-03-16 Heterocykliske forbindelser, deres fremstilling af anvendelse

Publications (1)

Publication Number Publication Date
CS68791A3 true CS68791A3 (en) 1992-02-19

Family

ID=8096500

Family Applications (1)

Application Number Title Priority Date Filing Date
CS91687A CS68791A3 (en) 1990-03-16 1991-03-15 Novel 1-carboxalkylquinoline-2,3(1h,4h)dione compounds, process for their preparation and use

Country Status (20)

Country Link
US (1) US5166155A (da)
EP (1) EP0520024B1 (da)
JP (1) JPH05505810A (da)
AT (1) ATE139530T1 (da)
AU (1) AU652560B2 (da)
CA (1) CA2078429A1 (da)
CS (1) CS68791A3 (da)
DE (1) DE69120400T2 (da)
DK (2) DK69790D0 (da)
ES (1) ES2089204T3 (da)
FI (1) FI924118A7 (da)
GR (1) GR3020560T3 (da)
HU (1) HUT62274A (da)
IE (1) IE910685A1 (da)
IL (1) IL97405A (da)
NO (1) NO179949C (da)
NZ (1) NZ237431A (da)
PT (1) PT97047B (da)
WO (1) WO1991013878A1 (da)
ZA (1) ZA911779B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT101004B (pt) * 1991-10-26 1999-10-29 Schering Ag Derivados da quinoxalina, processo para a sua preparacao e composicoes farmaceuticas que os contem
US6057304A (en) * 1992-10-26 2000-05-02 Schering Aktiengesellschaft Quinoxaline-phosphonic acid derivatives
PT647137E (pt) * 1992-06-22 2008-11-24 Univ California Antagonistas dos receptores da glicina e a sua utilização
FR2696466B1 (fr) * 1992-10-02 1994-11-25 Rhone Poulenc Rorer Sa Dérivés de 5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one, leur préparation et les médicaments les contenant.
IL109397A0 (en) * 1993-04-28 1994-07-31 Schering Ag Quinoxalinedione derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
DE4314592A1 (de) * 1993-04-28 1994-11-03 Schering Ag Benzo(f)chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
US5631373A (en) * 1993-11-05 1997-05-20 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones
DE4340045A1 (de) * 1993-11-24 1995-06-01 Basf Ag Neue Chinoxaline und Arzneimittel daraus
IL112235A (en) * 1994-01-03 2000-06-29 Acea Pharm Inc 1,4-dihydro-pyrido¬2,3-b¾pyrazine-2,3-dione (5 or 8) oxide derivatives and pharmaceutical compositions containing them
DE4428152A1 (de) * 1994-06-22 1996-01-04 Basf Ag Neue Amido-chinoxalindione, ihrer Herstellung und Verwendung
DE4436852A1 (de) * 1994-10-14 1996-04-18 Basf Ag Pyrrolyl-tetrahydrobenzochinoxalindione, ihre Herstellung und Verwendung
DE4439492A1 (de) * 1994-10-25 1996-05-02 Schering Ag Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
US5559447A (en) * 1994-11-17 1996-09-24 Cypress Semiconductor Output buffer with variable output impedance
DE19519979A1 (de) * 1995-05-24 1996-11-28 Schering Ag Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
DE19521058A1 (de) * 1995-06-09 1996-12-12 Basf Ag Verfahren zur Herstellung von Aromaten enthaltenden Polyetherpolyolen
DE19545251A1 (de) * 1995-11-24 1997-05-28 Schering Ag Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
GB9604400D0 (en) 1996-03-01 1996-05-01 Pfizer Ltd Compounds useful in therapy
DE19624808A1 (de) 1996-06-21 1998-01-02 Basf Ag Pyrrolylchinoxalindione, ihre Herstellung und Verwendung
ATE325128T1 (de) * 1996-10-24 2006-06-15 Novartis Pharma Gmbh Substituierte aminoalkanphosphonsäuren

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO179551C (no) * 1987-11-10 1996-10-30 Novo Nordisk As Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoxalinforbindelser
DK715888D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Quinoxalinforbindelser, deres fremstilling og anvendelse
DK716188D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Quinoxalinforbindelser, deres fremstilling og anvendelse

Also Published As

Publication number Publication date
NZ237431A (en) 1993-09-27
CA2078429A1 (en) 1991-09-17
GR3020560T3 (en) 1996-10-31
AU7576791A (en) 1991-10-10
AU652560B2 (en) 1994-09-01
IE910685A1 (en) 1991-09-25
WO1991013878A1 (en) 1991-09-19
ES2089204T3 (es) 1996-10-01
EP0520024A1 (en) 1992-12-30
NO179949C (no) 1997-01-15
PT97047A (pt) 1991-10-31
HU9202953D0 (en) 1992-12-28
HUT62274A (en) 1993-04-28
FI924118A0 (fi) 1992-09-15
NO179949B (no) 1996-10-07
ATE139530T1 (de) 1996-07-15
NO923586D0 (no) 1992-09-15
PT97047B (pt) 1998-07-31
IL97405A (en) 1995-12-08
IL97405A0 (en) 1992-06-21
NO923586L (no) 1992-09-15
FI924118L (fi) 1992-09-15
EP0520024B1 (en) 1996-06-19
DK69790D0 (da) 1990-03-16
DE69120400D1 (de) 1996-07-25
ZA911779B (en) 1991-12-24
US5166155A (en) 1992-11-24
DE69120400T2 (de) 1996-12-19
DK0520024T3 (da) 1996-10-14
FI924118A7 (fi) 1992-09-15
JPH05505810A (ja) 1993-08-26

Similar Documents

Publication Publication Date Title
CS68791A3 (en) Novel 1-carboxalkylquinoline-2,3(1h,4h)dione compounds, process for their preparation and use
US7109164B2 (en) Aniline-derived ligands for the thyroid receptor
JP3301024B2 (ja) グリシンレセプター拮抗物質及びその用途
DE3527648C2 (da)
KR960003324B1 (ko) 헤테로사이클릭 화합물, 이의 제조방법 및 이를 함유하는 약제학적 조성물
US5519019A (en) N-acyl-2,3-benzoidazepine derivatives, pharmaceutical compositions containing them and process for preparing same
IE65171B1 (en) Quinoxaline compounds and their preparation and use
US4492695A (en) Therapeutically useful imidazo[1,2-a]pyridine derivatives
SK283536B6 (sk) Pyridylftalazindióny, spôsob ich prípravy a použitie a farmaceutické prostriedky na ich báze
AT391694B (de) Verfahren zur herstellung von neuen ethylendiaminmonoamid-derivaten
NO162615B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4,5-tetrahydrobenz (c,d) indoler.
JP2000505793A (ja) 2,3―ベンゾジアゼピン誘導体及びそのampa―レセプター抑制剤としての使用
US5639751A (en) N-acyl-2,3-benzodiazepine derivatives for treating acute and chronic neurodegenerative disorders
DE68924556T2 (de) N-(N-(Tetrahydropyrido[2,3-d]pyrimidinylmethyl)-aminomethylbenzoyl)glutaminsäure-Derivate.
JPH06506442A (ja) 1−(4−アシルアミノフェニル)−7,8−メチレンジオキシ−5h−2,3−ベンゾ−ジアゼピン誘導体及びその酸付加塩、それを含む製薬学的組成物及びその製造方法
US5728709A (en) Alkyl and aralkyl-substituted pyrrolocarbazole derivatives that stimulate platelet production
KR840001133B1 (ko) 치환된 β-옥소-α-페닐-카바모일-피롤프로 피오니트릴의 제조방법
DE68917211T2 (de) N-(5,6,7,8-Tetrahydropyrido(2,3-d)pyrimidin-6-yl-alkanoyl)-glutaminsäure-Derivate.
PL165413B1 (pl) Sposób wytwarzania nowych pochodnych 6-arylo-5,6-dwuhydroimidazo [2,1-b] tiazolu PL PL
US5182279A (en) Benzothienopyrazinedione compounds and their preparation and use
JP2001512730A (ja) AMPA/カイニン酸レセプター・インヒビターとしての8−置換−9H−1,3−ジオキソロ[4,5−h][2,3]ベンゾジアゼピン誘導体
US4801590A (en) Pyrido(1,8)naphthyridinones, and their use as pharmaceuticals
NO792941L (no) Heterocykliske triklormetylderivater med metanreduserende virkning hos droevtyggere
JPH0560478B2 (da)
DE60209029T2 (de) Polycyclische verbindungen mit antitumor-wirkung